Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 109
Selected: 0
NCT IDTitle
NCT04162366A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
NCT03696160The Late Presenter Treatment Optimisation Study
NCT02249923Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
NCT04983030Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults
NCT00006371A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
NCT03503344Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT05109559Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine
NCT04240210Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
NCT00277654Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
NCT05304858Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT02987829Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
NCT00140426A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
NCT03290950A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
NCT05896748Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
NCT02307864Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
NCT03475628Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
NCT02938520Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
NCT03450057Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
NCT02841033Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT01947920A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
NCT02478632Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
NCT02471196Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT00214552Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT01236391Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT02422797Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
NCT02438631Placental Passage and Disposition of Drugs: A Physiology-based Approach
NCT06083922A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
NCT05523089The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
NCT02929745Single Cell Genomics of Psoriatic Skin
NCT01837862A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NCT01054573VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo
NCT01641367A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
NCT03063203Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
NCT03993847CLassification of Axial SpondyloarthritiS Inception Cohort
NCT04399551A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
NCT00215241Risperidone Augmentation for PTSD
NCT00177164Risperdal Consta for Bipolar Disorder
NCT06358638Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
NCT00959894Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
NCT03655223Early Check: Expanded Screening in Newborns
NCT04407442Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
NCT04775550DARA RVD For High Risk SMM
NCT06107738Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT00222807Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT03939182Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma